IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest F-1 SEC Filings
Registration statement for certain foreign private issuers

NYMOX PHARMACEUTICAL CORP, F-1, 2000-02-29


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission